Clinical trial
A Prospective Cohort Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Pain in the Musculoskeletal System
NCT07200362 is registered in ClinicalTrials.gov with Jiangsu Kanion Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Cohort Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Pain in the Musculoskeletal System
- Lead sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 30, 2021
- Completion date
- February 28, 2024
- Enrollment
- 3,029 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic primary musculoskeletal pain